Alexion's Klygefa Receives EU Approval for Generalised Myasthenia Gravis
Alexion’s Klygefa receives European Commission approval as an add-on treatment for adults with AChR antibody-positive generalised myasthenia gravis, based on Phase 3 PREVAIL trial results.
Phase 3 PREVAIL Trial | 17/11/2026 | By News Bureau
Alexion's Klygefa Receives EU Approval for Generalised Myasthenia Gravis
Alexion’s Klygefa receives European Commission approval as an add-on treatment for adults with AChR antibody-positive generalised myasthenia gravis, based on Phase 3 PREVAIL trial results.
Phase 3 PREVAIL Trial | 17/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy